

Seasoned medical device and biologic's sales professional specialized in introducing disruptive technology that improves patient outcomes. Experience that results in increased market share and better patient outcomes.
Introduced disruptive technology in the Osteoporosis/DEXA market to significantly improve standard of care.
Guided large hospital systems in the Midwest to adapt to improved fracture prevention technology that minimizes osteoporosis fracture due to poor bone quality testing that was considered the standard of care.
Increased sales from 0 - $889,000 specifically converting Cleveland Clinic to installing TBS onto DXA machines to improve standard of care.
Presented clinical data to establish new business with regenerative autologous culture chondrocyte grafts to improve patient out comes for orthopedic surgeons.
Introduced and supported first graphing process that supports cartilage regeneration for patients.
Increased allograft sales $700k - $1.3 million
Managed daily sales of grafts for ACL, achilles and osteochondral procedures.
Promotes Midwest Biologic Specialist and supported distributors in growing market share to 4.3 Million.
Provided OR coverage and education when necessary for medical staff and distributors.